This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
New Frontiers in Understanding Tumor Metabolism
joint with Immunometabolism in Immune Function and Inflammatory Disease
Organizer(s): Chi Van Dang, Katharine Yen and Navdeep S. Chandel
Date: February 21 - 25, 2016
Location: Fairmont Banff Springs, Banff, AB, Canada
Sponsored by Bayer HealthCare Pharmaceuticals, Cell Research, Merck & Co., Inc., Pfizer Inc. and Takeda Pharmaceutical Company Limited
Summary of Meeting:
This meeting will bring together experts in the field as well as newcomers, who are expected to enrich the conceptual framework for the study of tumor metabolism. Sessions are designed to bring the latest in basic biochemical work in metabolism to biologists, to deliver new findings in oncogenic transcriptional and post-transcriptional regulation of metabolism as a basis for further basic biochemical discoveries, and to provide foundational findings that lead to therapeutic applications of tumor metabolism research. The goals of these sessions are to: 1) Discuss new discoveries of previously unsuspected metabolic re-wiring in cancer, 2) Present current findings in transcriptional and post-transcriptional regulation of tumor metabolism and future challenges, and 3) Provide an update on opportunities for cancer therapy using knowledge generated from fundamental discoveries. New methods and knowledge will be shared at the meeting.
Scholarship Deadline: October 22 2015
Discounted Abstract Deadline: October 22 2015
Abstract Deadline: November 23 2015
Discounted Registration Deadline: December 21 2015
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bayer HealthCare PharmaceuticalsCell ResearchMerck & Co., Inc.Pfizer Inc.Takeda Pharmaceutical Company Limited
We gratefully acknowledge additional support for this conference from:
Cayman Chemical CompanyDon Whitley Scientific LimitedHypOxygen
Raze Therapeutics, Inc.
Seahorse Bioscience, a part of Agilent Technologies
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Calithera Biosciences, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA200104-01
Funding for this conference was made possible (in part) by 1R13CA200104-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found